Annual Net Income
-$36.06 M
+$30.66 M+45.95%
31 December 2022
Summary:
Eloxx Pharmaceuticals annual net profit is currently -$36.06 million, with the most recent change of +$30.66 million (+45.95%) on 31 December 2022. During the last 3 years, it has fallen by -$1.49 million (-4.30%). ELOX annual net income is now -462271.79% below its all-time high of -$7800.00, reached on 30 June 1997.ELOX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$3.59 M
+$749.00 K+17.25%
30 September 2023
Summary:
Eloxx Pharmaceuticals quarterly net profit is currently -$3.59 million, with the most recent change of +$749.00 thousand (+17.25%) on 30 September 2023. ELOX quarterly net income is now -1887.83% below its all-time high of -$180.70 thousand, reached on 30 September 2015.ELOX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$20.48 M
+$3.92 M+16.05%
30 September 2023
Summary:
Eloxx Pharmaceuticals TTM net profit is currently -$20.48 million, with the most recent change of +$3.92 million (+16.05%) on 30 September 2023. ELOX TTM net income is now -3996.40% below its all-time high of -$500.00 thousand, reached on 31 December 1999.ELOX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELOX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -4.3% | +63.7% | +66.3% |
| 5 y5 years | +23.6% | +72.1% | +61.5% |
ELOX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.3% | +46.0% | at high | +70.3% | at high | +70.6% |
| 5 y | 5 years | -4.3% | +46.0% | at high | +90.0% | at high | +70.6% |
| alltime | all time | <-9999.0% | +46.0% | -1887.8% | +90.0% | -3996.4% | +70.6% |
Eloxx Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$3.59 M(-17.3%) | -$20.48 M(-16.1%) |
| June 2023 | - | -$4.34 M(-30.3%) | -$24.40 M(-20.5%) |
| Mar 2023 | - | -$6.23 M(-1.4%) | -$30.68 M(-14.9%) |
| Dec 2022 | -$36.06 M(-46.0%) | -$6.32 M(-15.8%) | -$36.06 M(-13.8%) |
| Sept 2022 | - | -$7.51 M(-29.3%) | -$41.84 M(-5.4%) |
| June 2022 | - | -$10.62 M(-8.6%) | -$44.21 M(-36.5%) |
| Mar 2022 | - | -$11.62 M(-3.9%) | -$69.65 M(+4.4%) |
| Dec 2021 | -$66.73 M(+93.0%) | -$12.09 M(+22.3%) | -$66.73 M(+9.8%) |
| Sept 2021 | - | -$9.88 M(-72.6%) | -$60.76 M(+5.7%) |
| June 2021 | - | -$36.06 M(+314.7%) | -$57.50 M(+96.1%) |
| Mar 2021 | - | -$8.69 M(+41.9%) | -$29.32 M(-15.2%) |
| Dec 2020 | -$34.58 M(-32.0%) | -$6.13 M(-7.4%) | -$34.58 M(-13.7%) |
| Sept 2020 | - | -$6.62 M(-16.1%) | -$40.08 M(-13.5%) |
| June 2020 | - | -$7.89 M(-43.4%) | -$46.34 M(-12.4%) |
| Mar 2020 | - | -$13.95 M(+19.9%) | -$52.90 M(+4.0%) |
| Dec 2019 | -$50.87 M(+7.8%) | -$11.63 M(-9.6%) | -$50.87 M(-4.5%) |
| Sept 2019 | - | -$12.88 M(-10.9%) | -$53.27 M(+3.3%) |
| June 2019 | - | -$14.45 M(+21.2%) | -$51.55 M(+2.1%) |
| Mar 2019 | - | -$11.92 M(-15.0%) | -$50.51 M(+7.0%) |
| Dec 2018 | -$47.19 M(+122.4%) | -$14.03 M(+25.7%) | -$47.19 M(+42.3%) |
| Sept 2018 | - | -$11.16 M(-16.7%) | -$33.16 M(+42.5%) |
| June 2018 | - | -$13.41 M(+56.0%) | -$23.26 M(+96.1%) |
| Mar 2018 | - | -$8.59 M(+578.1%) | -$11.86 M(+93.6%) |
| Dec 2017 | -$21.21 M(+266.0%) | - | - |
| Sept 2017 | - | -$1.27 M(-36.9%) | -$6.13 M(+5.8%) |
| June 2017 | - | -$2.01 M(-2.9%) | -$5.80 M(+17.3%) |
| June 2017 | -$5.80 M(-29.9%) | - | - |
| Mar 2017 | - | -$2.07 M(+161.6%) | -$4.94 M(-17.0%) |
| Dec 2016 | - | -$789.80 K(-15.4%) | -$5.96 M(-34.0%) |
| Sept 2016 | - | -$933.60 K(-19.0%) | -$9.02 M(+9.1%) |
| June 2016 | -$8.27 M(-54.2%) | -$1.15 M(-62.6%) | -$8.27 M(+3.1%) |
| Mar 2016 | - | -$3.08 M(-20.1%) | -$8.02 M(+30.0%) |
| Dec 2015 | - | -$3.86 M(+2033.6%) | -$6.17 M(-52.8%) |
| Sept 2015 | - | -$180.70 K(-80.1%) | -$13.06 M(-27.7%) |
| June 2015 | -$18.06 M(+95.8%) | -$906.80 K(-26.1%) | -$18.06 M(-13.3%) |
| Mar 2015 | - | -$1.23 M(-88.6%) | -$20.83 M(-4.2%) |
| Dec 2014 | - | -$10.75 M(+107.3%) | -$21.75 M(+72.3%) |
| Sept 2014 | - | -$5.18 M(+41.1%) | -$12.62 M(+36.9%) |
| June 2014 | -$9.23 M(+50.7%) | -$3.67 M(+71.2%) | -$9.23 M(+23.3%) |
| Mar 2014 | - | -$2.15 M(+32.6%) | -$7.48 M(+21.2%) |
| Dec 2013 | - | -$1.62 M(-9.2%) | -$6.17 M(+6.0%) |
| Sept 2013 | - | -$1.78 M(-7.6%) | -$5.82 M(-4.9%) |
| June 2013 | -$6.12 M(+20.9%) | -$1.93 M(+130.8%) | -$6.12 M(+8.7%) |
| Mar 2013 | - | -$836.60 K(-34.1%) | -$5.63 M(-3.8%) |
| Dec 2012 | - | -$1.27 M(-39.1%) | -$5.86 M(-4.2%) |
| Sept 2012 | - | -$2.09 M(+44.9%) | -$6.11 M(+20.7%) |
| June 2012 | -$5.07 M(-30.3%) | -$1.44 M(+35.7%) | -$5.07 M(-20.1%) |
| Mar 2012 | - | -$1.06 M(-30.6%) | -$6.34 M(-5.2%) |
| Dec 2011 | - | -$1.53 M(+47.0%) | -$6.68 M(+6.2%) |
| Sept 2011 | - | -$1.04 M(-61.7%) | -$6.29 M(-13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | -$7.27 M(-45.7%) | -$2.71 M(+93.0%) | -$7.27 M(-32.5%) |
| Mar 2011 | - | -$1.41 M(+23.6%) | -$10.76 M(-26.5%) |
| Dec 2010 | - | -$1.14 M(-43.6%) | -$14.64 M(-3.7%) |
| Sept 2010 | - | -$2.02 M(-67.5%) | -$15.21 M(+13.6%) |
| June 2010 | -$13.38 M(+133.7%) | -$6.21 M(+17.5%) | -$13.38 M(+52.7%) |
| Mar 2010 | - | -$5.28 M(+210.2%) | -$8.77 M(+82.1%) |
| Dec 2009 | - | -$1.70 M(+800.0%) | -$4.81 M(+1.7%) |
| Sept 2009 | - | -$189.30 K(-88.1%) | -$4.73 M(-17.3%) |
| June 2009 | -$5.73 M(+24.5%) | -$1.59 M(+19.4%) | -$5.73 M(+14.1%) |
| Mar 2009 | - | -$1.33 M(-18.0%) | -$5.02 M(-12.4%) |
| Dec 2008 | - | -$1.62 M(+37.5%) | -$5.73 M(+6.1%) |
| Sept 2008 | - | -$1.18 M(+34.2%) | -$5.40 M(+17.4%) |
| June 2008 | -$4.60 M(+41.5%) | -$880.60 K(-56.9%) | -$4.60 M(+3.7%) |
| Mar 2008 | - | -$2.04 M(+57.9%) | -$4.44 M(+38.9%) |
| Dec 2007 | - | -$1.29 M(+238.9%) | -$3.19 M(+5.2%) |
| Sept 2007 | - | -$382.00 K(-46.5%) | -$3.03 M(-6.7%) |
| June 2007 | -$3.25 M(-1.9%) | -$714.30 K(-10.9%) | -$3.25 M(-2.2%) |
| Mar 2007 | - | -$801.30 K(-29.4%) | -$3.32 M(+2.6%) |
| Dec 2006 | - | -$1.14 M(+89.1%) | -$3.24 M(+7.3%) |
| Sept 2006 | - | -$600.50 K(-23.6%) | -$3.02 M(-8.9%) |
| June 2006 | -$3.31 M(+11.3%) | -$786.30 K(+9.6%) | -$3.31 M(+2.6%) |
| Mar 2006 | - | -$717.40 K(-21.5%) | -$3.23 M(-5.6%) |
| Dec 2005 | - | -$914.00 K(+1.9%) | -$3.42 M(+8.5%) |
| Sept 2005 | - | -$897.10 K(+27.9%) | -$3.15 M(+5.8%) |
| June 2005 | -$2.98 M(-20.1%) | -$701.20 K(-22.9%) | -$2.98 M(-12.1%) |
| Mar 2005 | - | -$908.90 K(+40.9%) | -$3.39 M(+17.0%) |
| Dec 2004 | - | -$645.20 K(-10.8%) | -$2.90 M(-5.0%) |
| Sept 2004 | - | -$723.60 K(-34.9%) | -$3.05 M(-18.2%) |
| June 2004 | -$3.73 M(+80.4%) | -$1.11 M(+166.5%) | -$3.73 M(+20.6%) |
| Mar 2004 | - | -$417.00 K(-47.8%) | -$3.09 M(-3.1%) |
| Dec 2003 | - | -$798.20 K(-43.0%) | -$3.19 M(+8.0%) |
| Sept 2003 | - | -$1.40 M(+195.7%) | -$2.95 M(+42.9%) |
| June 2003 | -$2.07 M(+6.5%) | -$473.60 K(-8.2%) | -$2.07 M(+6.3%) |
| Mar 2003 | - | -$515.70 K(-8.3%) | -$1.94 M(+1.7%) |
| Dec 2002 | - | -$562.40 K(+9.3%) | -$1.91 M(-2.2%) |
| Sept 2002 | - | -$514.60 K(+46.8%) | -$1.95 M(+0.7%) |
| June 2002 | -$1.94 M(+3.3%) | -$350.60 K(-27.4%) | -$1.94 M(-3.2%) |
| Mar 2002 | - | -$482.80 K(-20.2%) | -$2.00 M(+1.7%) |
| Dec 2001 | - | -$604.80 K(+20.6%) | -$1.97 M(+5.2%) |
| Sept 2001 | - | -$501.30 K(+21.0%) | -$1.87 M(-0.3%) |
| June 2001 | -$1.88 M(-23.2%) | -$414.40 K(-7.7%) | -$1.88 M(-10.0%) |
| Mar 2001 | - | -$448.90 K(-11.5%) | -$2.09 M(-15.4%) |
| Dec 2000 | - | -$507.40 K(+0.2%) | -$2.46 M(+0.3%) |
| Sept 2000 | - | -$506.30 K(-18.7%) | -$2.46 M(+26.0%) |
| June 2000 | -$2.44 M(+109.1%) | -$622.70 K(-24.7%) | -$1.95 M(+46.9%) |
| Mar 2000 | - | -$827.40 K(+65.5%) | -$1.33 M(+165.5%) |
| Dec 1999 | - | -$500.00 K | -$500.00 K |
| June 1999 | -$1.17 M(>+9900.0%) | - | - |
| June 1998 | -$10.40 K(+33.3%) | - | - |
| June 1997 | -$7800.00 | - | - |
FAQ
- What is Eloxx Pharmaceuticals annual net profit?
- What is the all time high annual net income for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Eloxx Pharmaceuticals?
What is Eloxx Pharmaceuticals annual net profit?
The current annual net income of ELOX is -$36.06 M
What is the all time high annual net income for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual net profit is -$7800.00
What is Eloxx Pharmaceuticals quarterly net profit?
The current quarterly net income of ELOX is -$3.59 M
What is the all time high quarterly net income for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly net profit is -$180.70 K
What is Eloxx Pharmaceuticals TTM net profit?
The current TTM net income of ELOX is -$20.48 M
What is the all time high TTM net income for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high TTM net profit is -$500.00 K